Company: MDCXW
Filing Date: 2025-04-04
Form Type: POS AM
Source: 0001062993-25-007073
Chunk: 147

Company: Medicus Pharma Ltd.
Filing Date: 2025-04-04
Form: POS AM
Chunk 147
---
 Board with respect to Board succession; and

•conducting annual performance assessments of the Board.

Executive Compensation

Named Executive Officers

Compensation of our named executive officers generally consists of the following elements: base salaries and participation in our equity incentive plan. The following table sets forth all compensation awarded to, or earned by, our named executive officers for the years ended December 31, 2024 and 2023.

| Name and                  
 principal position        
 Dr. Raza Bokhari, (1) CEO |  Fiscal Year 
        Ended 
 December 31, 
         2024 |     Salary 
        ($) 
          - | Share-based 
 Awards      
 ($)         
 -           | Option-based 
   Awards ($) 
   100,856.00 | Pension   
 Value ($) 
 -         |        All Other 
 Compensation ($) 
                - |        Total 
 Compensation 
          ($) 
   100,856.00 |
|:--------------------------|-------------:|-----------:|:------------|-------------:|:----------|-----------------:|-------------:|
|                           |         2023 |          - | -           |   132,600.68 | -         |                - |   132,600.68 |
| James Quinlan,            
 CFO                       |         2024 | 318,269.22 | -           |    40,342.00 | -         |          125,000 |   483,611.22 |
|                           |         2023 |  93,969.00 | -           |    66,300.34 | -         |          100,000 |   260,269.34 |
| Dr. Edward Brennan,       
 CSO, CMO (2)              |         2024 | 325,710.43 | -           |    40,342.00 | -         |          125,000 |   491,052.43 |
|                           |         2023 |  79,424.00 | -           |    39,780.06 | -         |           75,000 |   194,204.06 |

(1)Dr. Raza Bokhari provided executive services to the Company through an agreement between Medicus and RBx, an entity controlled by Dr. Bokhari. RBx also made available to the Company certain other management services and administrative and executive support. Reimbursable salaries paid to RBx pursuant to